PHARMACYCLICS INC
PCYC
PCYC was delisted on the 22nd of May, 2015.
280 hedge funds and large institutions have $5.29B invested in PHARMACYCLICS INC in 2014 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 103 increasing their positions, 83 reducing their positions, and 35 closing their positions.
89% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 35
24% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 83
11% more funds holding
Funds holding: 253 → 280 (+27)
2% more capital invested
Capital invested by funds: $5.19B → $5.29B (+$101M)
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
34% less call options, than puts
Call options by funds: $141M | Put options by funds: $213M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$365M |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$95.5M |
| 3 |
CCM
Cornerstone Capital Management
Edina,
Minnesota
|
+$66.9M |
| 4 |
FAM
Fred Alger Management
New York
|
+$51.2M |
| 5 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$123M |
| 2 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$71.6M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$70.7M |
| 4 |
CCI
Columbus Circle Investors
|
-$62.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$49M |
PCYC Hedge Fund Activity: Q1 2014 in Review
280 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q1 2014, worth a combined $5.29B — up 1.9% from $5.19B a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new PCYC positions and 35 closed out — a net gain of 31 holders — while 103 added to existing stakes and 83 trimmed.
The largest buyer was Ameriprise, adding an estimated $365M. The largest seller was T. Rowe Price Associates, cutting an estimated $123M.
- 280 institutional investors held PHARMACYCLICS INC (PCYC) as of Q1 2014, up from 253 in Q4 2013.
- Funds reported $5.29B of PHARMACYCLICS INC stock for Q1 2014, up 1.9% quarter-over-quarter.
- 66 funds opened new PHARMACYCLICS INC positions in Q1 2014 and 35 closed out, a net change of +31 holders.
- The largest PHARMACYCLICS INC buyer in Q1 2014 was Ameriprise, an estimated $365M added.
- The largest PHARMACYCLICS INC seller in Q1 2014 was T. Rowe Price Associates, an estimated $123M sold.
Based on aggregated 13F filings for Q1 2014.